RedPath Integrated Pathology, Inc. to Present at Rodman & Renshaw Global Investment Conference in New York

PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a molecular diagnostics company dedicated to the effective diagnosis and treatment of cancer, today announced that Mark D. Myslinski, RedPath’s president and chief executive officer, will share his perspectives on the rapidly expanding applications of molecular diagnostics at the Rodman and Renshaw 11th Annual Healthcare Conference. The conference will be held in New York City, September 9-11, 2009.